{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:00:31Z","timestamp":1781157631864,"version":"3.54.1"},"reference-count":67,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Psoriasis has been associated with cardiovascular risk, but the combined association of psoriasis and cardiovascular-kidney-metabolic (CKM) syndrome with mortality remains unclear. This study examined the individual and joint associations of CKM syndrome and self-reported psoriasis with allcause and cardio-cerebrovascular disease (CCD) mortality among 9,598 U.S. adults aged \u226520 years from NHANES 2003\u20132006 and 2009\u20132014. CKM syndrome stages were defined according to the 2023 American Heart Association framework, and psoriasis was assessed by self-reported physician diagnosis. Mortality was ascertained through linkage to the National Death Index through 2019. During a median follow-up of 9.3 years, 860 deaths occurred. Advanced CKM syndrome was associated with higher all-cause mortality (HR=3.67; 95% CI: 3.00\u20134.50) and CCD mortality (HR=8.16; 95% CI: 5.42\u201312.28). Psoriasis was also associated with higher all-cause mortality (HR=2.06; 95% CI: 1.47\u20132.90) and CCD mortality (HR=2.69; 95% CI: 1.42\u20135.08). Participants with both advanced CKM syndrome and psoriasis had the highest observed risks of all-cause mortality (HR=7.09; 95% CI: 4.93\u201310.19) and CCD mortality (HR=16.47; 95% CI: 7.26\u201337.33). Formal interaction testing did not show significant multi-plicative interaction for all-cause mortality (p for interaction=0.16) or CCD mortality (p for interaction=0.80). These findings suggest that coexisting advanced CKM syndrome and psoriasis may identify adults with particularly elevated mortality risk.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0241","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:30:04Z","timestamp":1781155804000},"source":"Crossref","is-referenced-by-count":0,"title":["Joint Relationship of Cardiovascular-kidney-metabolic Syndrome and Psoriasis with All-cause and Cause-specific Mortality in Adults: A Population-based Analysis"],"prefix":"10.2340","volume":"106","author":[{"given":"Junhan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"158564","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol 2021; 157: 940\u2013946.","DOI":"10.1001\/jamadermatol.2021.2007"},{"key":"158565","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 2020; 323: 1945\u20131960.","DOI":"10.1001\/jama.2020.4006"},{"key":"158566","doi-asserted-by":"crossref","unstructured":"Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther 2020; 37: 2017\u20132033.","DOI":"10.1007\/s12325-020-01346-6"},{"key":"158567","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases. J Am"},{"key":"158568","doi-asserted-by":"crossref","unstructured":"Acad Dermatol 2017; 76: 377\u2013390.","DOI":"10.1007\/s00393-017-0317-1"},{"key":"158569","doi-asserted-by":"crossref","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: apresidential advisory from the American Heart Association. Circulation 2023; 148: 1606\u20131635.","DOI":"10.1161\/CIR.0000000000001184"},{"key":"158570","unstructured":"Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, et al. Burden of disease"},{"key":"158571","unstructured":"scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study"},{"key":"158572","unstructured":"2021. Lancet 2024; 403: 2204\u20132256."},{"key":"158573","unstructured":"Tsai MK, Kao JTW, Wong CS, Liao CT, Lo WC, Chien KL, et al. Cardiovascular-kidney-metabolic syndrome and all-cause and"},{"key":"158574","doi-asserted-by":"crossref","unstructured":"cardiovascular mortality: a retrospective cohort study. PLoS Med 2025; 22: e1004629.","DOI":"10.1371\/journal.pmed.1004629"},{"key":"158575","unstructured":"Ostrominski JW, Arnold SV, Butler J, Fonarow GC, Hirsch JS, Palli SR, et al. Prevalence and overlap of cardiac, renal, and"},{"key":"158576","doi-asserted-by":"crossref","unstructured":"metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol 2023; 8: 1050\u20131060.","DOI":"10.1001\/jamacardio.2023.3241"},{"key":"158577","doi-asserted-by":"crossref","unstructured":"McDonald CJ, Calabresi P. Thromboembolic disorders associated with psoriasis. Arch Dermatol 1973; 107: 918.","DOI":"10.1001\/archderm.1973.01620210078025"},{"key":"158578","doi-asserted-by":"crossref","unstructured":"McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med 1973; 288: 912.","DOI":"10.1056\/NEJM197304262881715"},{"key":"158579","unstructured":"Singh S, Young P, Armstrong AW. Relationship between psoriasis and metabolic syndrome: a systematic review. G Ital"},{"key":"158580","unstructured":"Dermatol Venereol 2016; 151: 663\u2013677."},{"key":"158581","unstructured":"Chan WMM, Yew YW, Theng TSC, Liew CF, Oon HH. Prevalence of metabolic syndrome in patients with psoriasis: a crosssectional"},{"key":"158582","unstructured":"study in Singapore. smedj 2020; 61: 194\u2013199."},{"key":"158583","unstructured":"Furue M, Tsuji G, Chiba T, Kadono T. Cardiovascular and metabolic diseases comorbid with psoriasis: beyond the skin."},{"key":"158584","doi-asserted-by":"crossref","unstructured":"Intern Med 2017; 56: 1613\u20131619.","DOI":"10.2169\/internalmedicine.56.8209"},{"key":"158585","unstructured":"Picard D, B\u00e9nichou J, Sin C, Abasq C, Houivet E, Koning R, et al. Increased prevalence of psoriasis in patients with"},{"key":"158586","doi-asserted-by":"crossref","unstructured":"coronary artery disease: results from a case\u2013control study. Br J Dermatol 2014; 171: 580\u2013587.","DOI":"10.1111\/bjd.13155"},{"key":"158587","unstructured":"Pannu S, Rosmarin D. Psoriasis in patients with metabolic syndrome or type 2 diabetes mellitus: treatment challenges."},{"key":"158588","doi-asserted-by":"crossref","unstructured":"Am J Clin Dermatol 2021; 22: 293\u2013300.","DOI":"10.1007\/s40257-021-00590-y"},{"key":"158589","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and"},{"key":"158590","unstructured":"clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart"},{"key":"158591","unstructured":"Association. Circulation 2023; 148: 1636\u20131664."},{"key":"158592","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US"},{"key":"158593","doi-asserted-by":"crossref","unstructured":"adults, 2011\u20132020. JAMA 2024; 331: 1858\u20131860.","DOI":"10.1001\/jama.2024.6892"},{"key":"158594","unstructured":"Zhu X, Cheang I, Fu Y, Chen S, Liang G, Yuan H, et al. Comparative discrimination of Life\u2019s Simple 7, Life\u2019s Essential"},{"key":"158595","doi-asserted-by":"crossref","unstructured":"8, and Life\u2019s Crucial 9: evaluating the impact of added complexity on mortality prediction. BMC Med 2025; 23: 265.","DOI":"10.1186\/s12916-025-04116-9"},{"key":"158596","unstructured":"Li J, Wei X. Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: a"},{"key":"158597","doi-asserted-by":"crossref","unstructured":"prospective cohort study. Am J Prev Cardiol 2025; 22: 100985.","DOI":"10.1016\/j.ajpc.2025.100985"},{"key":"158598","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and"},{"key":"158599","doi-asserted-by":"crossref","unstructured":"cardiovascular mortality in individuals with Cardiovascular- Kidney-Metabolic syndrome. Cardiovasc Diabetol 2025; 24:","DOI":"10.1186\/s12933-025-02940-0"},{"key":"158600","unstructured":"183."},{"key":"158601","unstructured":"Qiu Z, Chen X, Geng T, Wan Z, Lu Q, Li L, et al. Associations of serum carotenoids with risk of cardiovascular mortality"},{"key":"158602","doi-asserted-by":"crossref","unstructured":"among individuals with type 2 diabetes: results from NHANES. Diabetes Care 2022; 45: 1453\u20131461.","DOI":"10.2337\/dc21-2371"},{"key":"158603","unstructured":"Zhu X, Cheang I, Tang Y, Shi M, Zhu Q, Gao R, et al. Associations of serum carotenoids with risk of all-cause and"},{"key":"158604","unstructured":"cardiovascular mortality in hypertensive adults. J Am Heart Assoc 2023; 12: e027568."},{"key":"158605","unstructured":"Patrick MT, Li Q, Wasikowski R, Mehta N, Gudjonsson JE, Elder JT, et al. Shared genetic risk factors and causal association"},{"key":"158606","unstructured":"between psoriasis and coronary artery disease. Nat Commun 2022; 13: 6565."},{"key":"158607","unstructured":"Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, et al. The relationship between duration of psoriasis, vascular"},{"key":"158608","doi-asserted-by":"crossref","unstructured":"inflammation, and cardiovascular events. J Am Acad Dermatol 2017; 77: 650\u2013656.","DOI":"10.1016\/j.jaad.2017.06.028"},{"key":"158609","unstructured":"Kan J, Chen Q, Tao Q, Wu L, Wang D, Jiang Z, et al. Prospective evaluation of cardiovascular risk and mortality in"},{"key":"158610","unstructured":"patients with psoriasis: an American population-based study. Exp Dermatol 2024; 33: e15010."},{"key":"158611","unstructured":"Dhana A, Yen H, Yen H, Cho E. All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis."},{"key":"158612","doi-asserted-by":"crossref","unstructured":"J Am Acad Dermatol 2019; 80: 1332\u20131343.","DOI":"10.1016\/j.jaad.2018.12.037"},{"key":"158613","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, et al. Association between different stages of cardiovascular-kidney-metabolic"},{"key":"158614","doi-asserted-by":"crossref","unstructured":"syndrome and the risk of all-cause mortality. Atherosclerosis 2024; 397: 118585.","DOI":"10.1016\/j.atherosclerosis.2024.118585"},{"key":"158615","unstructured":"Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative incidence of mortality associated with cardiovascularkidney-"},{"key":"158616","doi-asserted-by":"crossref","unstructured":"metabolic (CKM) syndrome. J Am Soc Nephrol 2025; 36: 1343\u20131351.","DOI":"10.1681\/ASN.0000000637"},{"key":"158617","unstructured":"Zhao H, Wu J, Wu Q. Synergistic impact of psoriasis and hypertension on all-cause mortality risk: a prospective cohort"},{"key":"158618","doi-asserted-by":"crossref","unstructured":"study. PLoS One 2024; 19: e0306048.","DOI":"10.1371\/journal.pone.0306048"},{"key":"158619","unstructured":"Lu J, Li H, Wang S. Interaction effect of psoriasis and chronic kidney disease on the risk of all-cause mortality:"},{"key":"158620","doi-asserted-by":"crossref","unstructured":"a prospective cohort study of NHANES data. Nephrol Dial Transplant 2023; 38: 2474\u20132484.","DOI":"10.1093\/ndt\/gfad089"},{"key":"158621","doi-asserted-by":"crossref","unstructured":"Kong X, Wang W. Synergistic effect of psoriasis and metabolic syndrome on risk of all-cause and cardiovascular mortality in US adults: a nationwide cohort study. Clin Exp Dermatol 2024; 50: 113\u2013119.","DOI":"10.1093\/ced\/llae340"},{"key":"158622","unstructured":"Piaserico S, Orlando G, Messina F. Psoriasis and cardiometabolic diseases: shared genetic and molecular"},{"key":"158623","doi-asserted-by":"crossref","unstructured":"pathways. Int J Mol Sci 2022; 23: 23.","DOI":"10.3390\/ijms232112949"},{"key":"158624","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Blauvelt A, Callis Duffin K, Huang YH, Savage LJ, Guo L, et al. Psoriasis. Nat Rev Dis Primers 2025; 11: 45.","DOI":"10.1038\/s41572-025-00630-5"},{"key":"158625","unstructured":"Egeberg A, Gisondi P, Carrascosa JM, Warren RB, Mrowietz U. The role of the interleukin-23\/Th17 pathway in"},{"key":"158626","doi-asserted-by":"crossref","unstructured":"cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol 2020; 34: 1695\u20131706.","DOI":"10.1111\/jdv.16273"},{"key":"158627","unstructured":"Pinter A, Schwarz P, Gerdes S, Simon JC, Saalbach A, Rush J, et al. Biologic treatment in combination with lifestyle"},{"key":"158628","unstructured":"intervention in moderate to severe plaque psoriasis and concomitant metabolic syndrome: rationale and methodology"},{"key":"158629","doi-asserted-by":"crossref","unstructured":"of the METABOLyx randomized controlled clinical trial. Nutrients 2021; 13: 3015.","DOI":"10.3390\/nu13093015"},{"key":"158630","doi-asserted-by":"crossref","unstructured":"Flammer AJ, Ruschitzka F. Psoriasis and atherosclerosis: two plaques, one syndrome? Eur Heart J 2012; 33: 1989\u20131991.","DOI":"10.1093\/eurheartj\/ehr425"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46298\/54302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46298\/54303","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46298\/54304","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46298\/54306","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46298\/54302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:31:19Z","timestamp":1781155879000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":67,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0241","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}